Kinnos Publishes Paper Demonstrating Highlight® Does Not Reduce Antimicrobial Efficacy of Disinfectants and is Safe for Skin Contact

New York, May 24, 2018 – Kinnos Inc. on Thursday published a major article in American Journal of Infection Control. The study, conducted with funding from the USAID Fighting Ebola Grand Challenge, compared efficacy and safety of major chlorine disinfectants with and without the Highlight® color additive. Highlight® colorizes bleach solutions to visualize full coverage, modifies the liquid properties to allow bleach solutions to fully spread and adhere to waterproof surfaces, and fades in color to indicate when the contact time has been met and decontamination is done.

"Highlight® is considered an adjuvant by the EPA and does not require formal product registration," said Kevin Tyan, the lead author of the study and Chief Technology Officer at Kinnos. "However, it was important for us to confirm that Highlight® is safe to use and that adding it to a disinfectant does not reduce the disinfectant's antimicrobial efficacy." Using ASTM and AOAC standard tests for bacteria and viruses including S. aureus, P. aeruginosa, V. cholerae, and human coronavirus, Tyan et al. found no difference in log kill or contact time between sodium hypochlorite, calcium hypochlorite, or sodium dichloroisocyanurate (NaDCC) alone versus the same disinfectants combined with Highlight®, except in one case where Highlight®-enhanced sodium hypochlorite yielded greater efficacy against human coronavirus than sodium hypochlorite alone. An ISO standard primary skin irritation test was also conducted comparing disinfectant alone versus disinfectant with Highlight® and all cases were found to be negligible irritants, which is the lowest possible rating for this test.

The full study can be found here. All literature published on Highlight® is available at: www.kinnos.us/whitepapers

About Kinnos Inc.

Kinnos (Brooklyn, NY) develops tools that raise the standard of infection prevention to protect healthcare workers, patients, and the general public from infection. Their first product, Highlight®, is a patent-pending point-of-use additive that greatly improves visibility, coverage, and end-user compliance of disinfectants. Highlight® is used by HazMat and biosafety units, was a winner of the USAID Fighting Ebola Grand Challenge, and has been field-tested by NGOs and healthcare workers in Liberia, Guinea, and Haiti. Highlight® will soon be available for bleach wipes in hospitals. For more information, visit: www.kinnos.us

Media Contact:

Kinnos Inc.
team@kinnos.us